ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,070.55
      1.20%
      US Tech 100
      17,071.60
      1.90%
      Dow Jones
      38,503.69
      0.69%
      Brent Oil
      87.565
      1.34%
      Bitcoin
      66,390.40
      -0.70%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Indaptus Therapeutics Inc (INDP)

      7. Indaptus Therapeutics Inc (INDP) News

      INDP Indaptus Therapeutics Inc

      2.49
      0.05 (2.05%)
      After Hours
      Last Updated: 18:00:06
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Indaptus Therapeutics Inc INDP NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.05 2.05% 2.49 18:00:06
      Open Price Low Price High Price Close Price Prev Close
      2.44 2.44 2.68 2.49 2.44
      more quote information »

      Recent News

      Date Time Source Heading
      4/11/202407:30GLOBEIndaptus Therapeutics Presents Positive Mechanism of Action..
      3/28/202408:00GLOBEIndaptus Therapeutics to Present at the MedInvest Biotech..
      3/25/202408:30GLOBEIndaptus Therapeutics Previews Positive Mechanism of Action..
      3/18/202408:00GLOBEIndaptus Therapeutics to Participate in Tribe Public Webinar..
      3/13/202407:30GLOBEIndaptus Therapeutics Reports Fourth Quarter and Year-End..
      3/04/202411:01EDGAR2Form 8-K - Current report
      3/04/202407:30GLOBEIndaptus Therapeutics Announces Positive Results from Second..
      2/15/202408:00GLOBEIndaptus Therapeutics to Present at the 2024 BIO CEO &..
      2/08/202408:00GLOBEIndaptus Therapeutics Expands Digital Presence with Launch..
      1/23/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/23/202416:05EDGAR2Form 8-K - Current report
      1/04/202408:00GLOBEEuropean Patent Office Approves Key Patent for Indaptus..
      11/06/202316:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/06/202316:05EDGAR2Form 8-K - Current report
      11/06/202316:01GLOBEIndaptus Therapeutics Reports Third Quarter 2023 Financial..
      11/06/202308:13EDGAR2Form 8-K - Current report
      11/06/202308:00GLOBEIndaptus Therapeutics’ Decoy20 Demonstrated a Broad Immune..
      10/31/202309:12EDGAR2Form 8-K - Current report
      10/31/202309:01GLOBEIndaptus Therapeutics to Present Positive Pharmacodynamic..
      9/27/202308:00GLOBEIndaptus Therapeutics to Present at the LD Micro Main Event..
      9/26/202308:00GLOBERegistration Is Now Open For Tribe Public’s Webinar Event..
      9/19/202308:00GLOBEIndaptus Therapeutics Doses First Patient in Second Cohort..
      9/06/202308:05GLOBEIndaptus Therapeutics to Present at the H.C. Wainwright 25th..
      8/16/202318:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/14/202308:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      8/14/202308:10EDGAR2Form 8-K - Current report
      8/14/202308:00GLOBEIndaptus Therapeutics Reports Second Quarter 2023 Financial..
      8/10/202308:45EDGAR2Form 8-K - Current report
      8/10/202308:45GLOBEIndaptus Therapeutics Announces Opening of Next Cohort in..
      8/07/202308:00GLOBEIndaptus Therapeutics Appoints Industry Veteran Roger..
      6/15/202308:00GLOBEIndaptus Therapeutics to Participate in the Maxim Group..
      5/31/202308:30GLOBEIndaptus Therapeutics to Present at the Jefferies Healthcare..
      5/11/202307:00GLOBEIndaptus Therapeutics Reports First Quarter 2023 Financial..
      5/09/202308:00GLOBEFollowing Granting of Indian Patent, Indaptus Therapeutics..
      5/01/202308:00GLOBEIndaptus Therapeutics’ Chief Scientific Officer Michael..

      Your Recent History

      NASDAQ
      INDP
      Indaptus Therapeutics
      Delayed Upgrade Clock